{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:00Z","timestamp":1707525120166},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,22]]},"DOI":"10.7759\/cureus.40829","type":"journal-article","created":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T06:49:07Z","timestamp":1687502947000},"source":"Crossref","is-referenced-by-count":0,"title":["Pediatric Ulcerative Colitis in Siblings"],"prefix":"10.7759","author":[{"given":"Divya","family":"Mamootil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002035","article-title":"Management of paediatric ulcerative colitis, part 1: ambulatory care-an evidence-based guideline from European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition","volume":"67","author":"Turner D","year":"2018","unstructured":"Turner D, Ruemmele FM, Orlanski-Meyer E, et al.. Management of paediatric ulcerative colitis, part 1: ambulatory care-an evidence-based guideline from European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018, 67:257-91. 10.1097\/MPG.0000000000002035","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000085","article-title":"Role of genetics in pediatric inflammatory bowel disease","volume":"20","author":"Okou DT","year":"2014","unstructured":"Okou DT, Kugathasan S. Role of genetics in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2014, 20:1878-84. 10.1097\/MIB.0000000000000085","journal-title":"Inflamm Bowel Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpg.0000163736.30261.82","article-title":"Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria","volume":"41","author":"IBD Working Group of the European Society for Paediatric Gastroenterology","year":"2005","unstructured":"IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria. J Pediatr Gastroenterol Nutr. 2005, 41:1-7. 10.1097\/01.mpg.0000163736.30261.82","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7440.1","article-title":"Genetics and therapeutics in pediatric ulcerative colitis: the past, present and future","volume":"5","author":"Sifuentes-Dominguez L","year":"2016","unstructured":"Sifuentes-Dominguez L, Patel AS. Genetics and therapeutics in pediatric ulcerative colitis: the past, present and future. F1000Res. 2016, 5:10.12688\/f1000research.7440.1","journal-title":"F1000Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/003655202761020588","article-title":"Siblings and the risk of inflammatory bowel disease","volume":"37","author":"Montgomery SM","year":"2002","unstructured":"Montgomery SM, Lambe M, Wakefield AJ, Pounder RE, Ekbom A. Siblings and the risk of inflammatory bowel disease. Scand J Gastroenterol. 2002, 37:1301-8. 10.1080\/003655202761020588","journal-title":"Scand J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3176","article-title":"High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis","volume":"47","author":"Goyette P","year":"2015","unstructured":"Goyette P, Boucher G, Mallon D, et al.. High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat Genet. 2015, 47:172-9. 10.1038\/ng.3176","journal-title":"Nat Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20213","article-title":"Pediatric inflammatory bowel disease: clinical and molecular genetics","volume":"13","author":"Biank V","year":"2007","unstructured":"Biank V, Broeckel U, Kugathasan S. Pediatric inflammatory bowel disease: clinical and molecular genetics. Inflamm Bowel Dis. 2007, 13:1430-8. 10.1002\/ibd.20213","journal-title":"Inflamm Bowel Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.04.020","article-title":"Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection","volume":"131","author":"Van der Sluis M","year":"2006","unstructured":"Van der Sluis M, De Koning BA, De Bruijn AC, et al.. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology. 2006, 131:117-29. 10.1053\/j.gastro.2006.04.020","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.10.032","article-title":"Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship","volume":"136","author":"Anderson CA","year":"2009","unstructured":"Anderson CA, Massey DC, Barrett JC, et al.. Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology. 2009, 136:523-9.e3. 10.1053\/j.gastro.2008.10.032","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ng.275","article-title":"Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study","volume":"41","author":"Silverberg MS","year":"2009","unstructured":"Silverberg MS, Cho JH, Rioux JD, et al.. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet. 2009, 41:216-20. 10.1038\/ng.275","journal-title":"Nat Genet"},{"key":"ref11","article-title":"Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic","volume":"89","author":"Cabrera-Abreu J","year":"2004","unstructured":"Cabrera-Abreu J, Davies P, Matek Z, Murphy M. Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic. Arch Dis Child. 2004, 89:69-71.","journal-title":"Arch Dis Child"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07458.x","article-title":"Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation","volume":"98","author":"Kane S","year":"2003","unstructured":"Kane S, Sandborn WJ, Rufo PA, et al.. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol. 2003, 98:1309-1314. 10.1111\/j.1572-0241.2003.07458.x","journal-title":"Am J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21561","article-title":"Fecal osteoprotegerin may guide the introduction of second-line therapy in hospitalized children with ulcerative colitis","volume":"17","author":"Sylvester FA","year":"2011","unstructured":"Sylvester FA, Turner D, Draghi A 2nd, et al.. Fecal osteoprotegerin may guide the introduction of second-line therapy in hospitalized children with ulcerative colitis. Inflamm Bowel Dis. 2011, 17:1726-30. 10.1002\/ibd.21561","journal-title":"Inflamm Bowel Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2014.00006","article-title":"Fecal biomarkers of intestinal health and disease in children","volume":"2","author":"Pang T","year":"2014","unstructured":"Pang T, Leach ST, Katz T, Day AS, Ooi CY. Fecal biomarkers of intestinal health and disease in children. Front Pediatr. 2014, 2:6. 10.3389\/fped.2014.00006","journal-title":"Front Pediatr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20336","article-title":"Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children","volume":"14","author":"Sidler MA","year":"2008","unstructured":"Sidler MA, Leach ST, Day AS. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Inflamm Bowel Dis. 2008, 14:359-66. 10.1002\/ibd.20336","journal-title":"Inflamm Bowel Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-1184","article-title":"Management of acute severe colitis in children with ulcerative colitis in the biologics era","volume":"137","author":"Romano C","year":"2016","unstructured":"Romano C, Syed S, Valenti S, Kugathasan S. Management of acute severe colitis in children with ulcerative colitis in the biologics era. Pediatrics. 2016, 137:10.1542\/peds.2015-1184","journal-title":"Pediatrics"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2014-307218","article-title":"Management of ulcerative colitis","volume":"101","author":"Fell JM","year":"2016","unstructured":"Fell JM, Muhammed R, Spray C, Crook K, Russell RK. Management of ulcerative colitis. Arch Dis Child. 2016, 101:469-74. 10.1136\/archdischild-2014-307218","journal-title":"Arch Dis Child"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan BG","year":"2013","unstructured":"Feagan BG, Rutgeerts P, Sands BE, et al.. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013, 369:699-710. 10.1056\/NEJMoa1215734","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.05.010","article-title":"Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: a preliminary report","volume":"8","author":"Turner D","year":"2014","unstructured":"Turner D, Levine A, Kolho KL, Shaoul R, Ledder O. Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: a preliminary report. J Crohns Colitis. 2014, 8:1464-70. 10.1016\/j.crohns.2014.05.010","journal-title":"J Crohns Colitis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e318292fa0d","article-title":"Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis","volume":"56","author":"Kunde S","year":"2013","unstructured":"Kunde S, Pham A, Bonczyk S, et al.. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr. 2013, 56:597-601. 10.1097\/MPG.0b013e318292fa0d","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/163976-pediatric-ulcerative-colitis-in-siblings","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:48Z","timestamp":1707509088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/163976-pediatric-ulcerative-colitis-in-siblings"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.40829","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,22]]}}}